// App-Quantinova.ai

11008 : Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses.

Researchers

Presenter

  • Melissa Amber Burgess

Principal Investigators

  • Brian Andrew Van Tine

  • Scott Schuetze

  • James Hu

  • Sandra P. D'Angelo

  • Steven Attia

  • Dennis A. Priebat

  • Scott H. Okuno

  • Richard F. Riedel

  • Lara Emily Davis

  • Sujana Movva

  • Damon R. Reed

  • Lisa Helene Butterfield

  • Jason Roszik

  • Denise K. Reinke

  • Laurence H. Baker

  • Robert G. Maki

  • Shreyaskumar Patel

  • Hussein Abdul-Hassan Tawbi

Medical Centers

  • University of Pittsburgh, Pittsburgh, PA

  • Cancer Research and Biostats, Seattle, WA

  • Washington University in St Louis, St. Louis, MO

  • University of Michigan, Ann Arbor, MI

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • Department of Surgery, Gynecologic Service, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Mayo Clinic, Jacksonville, FL

  • Medstar Washington Hosp Ctr, Washington, DC

  • Mayo Clinic, Rochester, MN

  • Duke University Medical Center, Durham, NC

  • Oregon Health and Science University, Portland, OR

  • Fox Chase Cancer Center, Philadelphia, PA

  • Moffitt Cancer Center, Tampa, FL

  • University of Pittsburgh Cancer Institute, UPMC Cancer Center, Pittsburgh, PA

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • SARC, Ann Arbor, MI

  • Monter Cancer Center, Northwell Health and Cold Spring Harbor Laboratory, Lake Success, NY

  • The University of Texas MD Anderson Cancer Center Department of Gastrointestinal Medical Oncology, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

  • Tumor protein p63

  • T-cell receptor

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • II

Study Id's

  • NCT02301039

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved